Cardiac Dimensions
Cardiac Dimensions is a privately held structural-heart medical device company headquartered in Kirkland, Washington, developing transcatheter therapies for patients with heart failure and functional mitral regurgitation. Its lead product is the CARILLON Mitral Contour System, a minimally invasive, catheter-delivered implant placed in the coronary sinus to reshape the mitral valve annulus and reduce functional mitral regurgitation without open-heart surgery. CARILLON carries a CE Mark in Europe and remains an investigational device in the United States, where the company is completing the EMPOWER pivotal trial. Cardiac Dimensions closed an oversubscribed $53M Series E in March 2025 led by Ally Bridge Group. The company manufactures an implantable Class III medical device and operates no public developer program, API, or software platform.
Cardiac Dimensions is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Cardiology, Heart Failure, and Structural Heart.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API